Xeris Biopharma Holdings
XERS
XERS
134 hedge funds and large institutions have $136M invested in Xeris Biopharma Holdings in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2.24% less ownership
Funds ownership: 43.16% → 40.91% (-2.2%)
6% less funds holding
Funds holding: 143 → 134 (-9)
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
Holders
134
Holding in Top 10
2
Calls
$932K
Puts
$202K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$1.34M | |
| 3 | +$836K | |
| 4 |
Renaissance Technologies
New York
|
+$770K |
| 5 |
Morgan Stanley
New York
|
+$718K |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.32M | |
| 3 | -$926K | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$687K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$558K |